HS-10386
/ Jiangsu Hansoh Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 22, 2023
A Phase I Study of HS-10386 in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=248 | Recruiting | Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
IO biomarker • Metastases • New P1 trial • Oncology • Solid Tumor • PD-L1
1 to 1
Of
1
Go to page
1